TGF-β1 treatment of HepG2 cells in both types of scaffolds, in either mono-culture or co-cultures, induced fibronectin-1 and TGF-β1 mRNA expression, suggesting HCC progression [49]. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.